Virtual Medicinal Product (VMP) - Insulin isophane biphasic porcine 30/70 100units/ml suspension for injection 10ml vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Insulin isophane biphasic porcine 30/70 100units/ml suspension for injection 10ml vials Start Date 25-06-2004 End Date
Previous Name Previous Name Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vials Start Date 17-12-2002 End Date 24-06-2004
Abbreviated Name Abbreviated Name Insulin isophane biphas porc 30/70 100units/ml inj 10ml Start Date 01-05-2009
Previous Abbreviated Name Insulin isophane biphas porc 30/70 100units/ml inj 10ml vl Previous Start Date 06-10-2005 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
10.0
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular, Subcutaneous
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.subcutaneous, suspensioninjection.intramuscular
Name Basis
BAN - British Approved Name

Codes

ATC Code
A10AD03
BNF Start Date End Date
Current BNF 06010102 Start Date 04-04-2022 End Date
Previous BNF 06010102 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
3472011000001108 17-12-2002

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Insulin isophane porcine Based on Base Substance Insulin porcine 70 unit 1 ml
Insulin soluble porcine Based on Base Substance Insulin porcine 30 unit 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 3939 Part VIIIA Category C